Under an agreement with the Securities and Exchange Commission, Theranos Inc. founder Elizabeth Holmes has agreed to pay a $500,000 fine in order to settle charges of fraud, U.S. regulators announced Wednesday. Theranos once had a $9 billion valuation, and claimed that it could change the way blood was analyzed in a laboratory.